These interactions further reinforce the hypothesis that hormonal signaling, particularly via ERα and ERβ, contributes to the immune landscape of NSCLC by modulating PD-L1 expression through multiple, context-dependent molecular pathways. The gene discussed is CD274; the disease is non-small cell lung carcinoma.